Envista Holdings Cash on Hand 2018-2025 | NVST

Envista Holdings cash on hand from 2018 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Envista Holdings Annual Cash on Hand
(Millions of US $)
2025 $1,212
2024 $1,069
2023 $940
2022 $607
2021 $1,074
2020 $889
2019 $211
2018
2017
Envista Holdings Quarterly Cash on Hand
(Millions of US $)
2025-09-30 $1,134
2025-06-30 $1,111
2025-03-31 $1,077
2024-12-31 $1,069
2024-09-30 $991
2024-06-30 $1,036
2024-03-31 $949
2023-12-31 $940
2023-09-30 $824
2023-06-30 $652
2023-03-31 $585
2022-12-31 $607
2022-09-30 $569
2022-06-30 $523
2022-03-31 $1,078
2021-12-31 $1,074
2021-09-30 $639
2021-06-30 $554
2021-03-31 $441
2020-12-31 $889
2020-09-30 $701
2020-06-30 $822
2020-03-31 $354
2019-12-31 $211
2019-09-30 $193
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.747B $2.720B
Envista Holdings Corporation manufactures and sells dental products primarily in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics and dental eye loupes to oral surgeons, prosthodontists and periodontists; Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. Envista Holdings Corporation is based in Brea, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $195.936B 21.88
EssilorLuxottica (ESLOY) France $142.091B 0.00
Stryker (SYK) United States $140.083B 26.86
Medtronic (MDT) Ireland $127.548B 17.67
Boston Scientific (BSX) United States $110.783B 24.50
Medline (MDLN) United States $58.526B 0.00
Lonza Group Ag (LZAGY) Switzerland $48.093B 0.00
ResMed (RMD) United States $36.791B 24.57
GE HealthCare Technologies (GEHC) United States $36.615B 17.54
Agilent Technologies (A) United States $35.584B 22.55
Koninklijke Philips (PHG) Netherlands $30.091B 17.86
Terumo (TRUMY) Japan $21.610B 25.26
Zimmer Biomet Holdings (ZBH) United States $19.115B 11.76
Insulet (PODD) United States $17.076B 53.00
Smith & Nephew SNATS (SNN) United Kingdom $15.372B 0.00
Baxter (BAX) United States $10.182B 8.72
Sunny Optical Technology (SNPTF) China $8.485B 0.00
Bio-Rad Laboratories (BIO) United States $6.921B 25.86
Demant (WILYY) Denmark $6.042B 0.00
Lantheus Holdings (LNTH) United States $4.601B 14.02
BillionToOne (BLLN) United States $4.056B 0.00
ICU Medical (ICUI) United States $3.577B 22.71
Shandong Weigao Medical Polymer (SHWGF) China $3.263B 0.00
Prestige Consumer Healthcare (PBH) United States $3.160B 14.91
Haemonetics (HAE) United States $2.684B 11.74
Neogen (NEOG) United States $2.380B 52.10
Phibro Animal Health (PAHC) United States $2.118B 18.66
Perrigo (PRGO) Ireland $2.001B 5.01
LeMaitre Vascular (LMAT) United States $1.989B 40.03
Curaleaf Holdings (CURLF) Canada $1.642B 0.00
AtriCure (ATRC) United States $1.623B 0.00
QuidelOrtho (QDEL) United States $1.602B 11.12
Kestra Medical Technologies (KMTS) United States $1.571B 0.00
Green Thumb Industries (GTBIF) United States $1.446B 63.36
AdaptHealth (AHCO) United States $1.381B 20.00
Lumexa Imaging Holdings (LMRI) United States $1.358B 0.00
BioLife Solutions (BLFS) United States $1.070B 317.57
Capricor Therapeutics (CAPR) United States $1.026B 0.00
InMode (INMD) Israel $0.906B 9.93
Tilray Brands (TLRY) Canada $0.875B 0.00
Valneva SE (VALN) France $0.868B 0.00
Omeros (OMER) United States $0.829B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.757B 0.00
CeriBell (CBLL) United States $0.733B 0.00
VAREX IMAGING (VREX) United States $0.566B 13.52
Brainsway (BWAY) Israel $0.451B 76.63
Canopy Growth (CGC) Canada $0.436B 0.00
Cerus (CERS) United States $0.430B 0.00
Verano Holdings (VRNO) United States $0.396B 0.00
SNDL (SNDL) Canada $0.386B 0.00
Cresco Labs (CRLBF) United States $0.361B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.328B 0.00
Viemed Healthcare (VMD) United States $0.315B 25.09
Evolus (EOLS) United States $0.279B 0.00
Quanterix (QTRX) United States $0.268B 0.00
TriSalus Life Sciences (TLSI) United States $0.243B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Sanuwave Health (SNWV) United States $0.213B 0.00
Utah Medical Products (UTMD) United States $0.205B 18.42
High Tide (HITI) Canada $0.203B 0.00
Aurora Cannabis (ACB) Canada $0.201B 59.17
OraSure Technologies (OSUR) United States $0.197B 0.00
TerrAscend (TSNDF) Canada $0.182B 0.00
Organigram Global (OGI) Canada $0.174B 0.00
Accendra Health (ACH) United States $0.173B 1.74
Vireo Growth (VREOF) United States $0.170B 0.00
Sanara MedTech (SMTI) United States $0.168B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Apyx Medical (APYX) United States $0.142B 0.00
FitLife Brands (FTLF) United States $0.134B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.129B 0.00
Fonar (FONR) United States $0.115B 16.42
MacroGenics (MGNX) United States $0.108B 0.00
Jushi Holdings (JUSHF) United States $0.100B 0.00
Biote (BTMD) United States $0.097B 4.26
Exagen (XGN) United States $0.074B 0.00
ImmuCell (ICCC) United States $0.060B 25.39
Sharps Technology (STSS) United States $0.051B 0.00
Nephros (NEPH) United States $0.044B 31.54
Cytosorbents (CTSO) United States $0.040B 0.00
Rockwell Medical (RMTI) United States $0.040B 0.00
Veru (VERU) United States $0.037B 0.00
Modular Medical (MODD) United States $0.035B 0.00
United-Guardian (UG) United States $0.030B 15.35
Jin Medical (ZJYL) China $0.022B 0.00
Bonk (BNKK) United States $0.021B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
INLIF (INLF) China $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Agape ATP (ATPC) $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00